• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/13/23 1:40:34 PM ET
    $ABM
    $BLBX
    $BQ
    $CALM
    Diversified Commercial Services
    Consumer Discretionary
    EDP Services
    Technology
    Get the next $ABM alert in real time by email

    Shares of Despegar.com, Corp. (NYSE:DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance.

    The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.

    Despegar.com shares gained 16.4% to $9.90 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Shattuck Labs, Inc. (NASDAQ:STTK) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.
    • ReShape Lifesciences Inc. (NASDAQ:RSLS) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.
    • C4 Therapeutics, Inc. (NASDAQ:CCCC) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12.
    • RiskOn International, Inc. (NASDAQ:ROI) shares gained 38.3% to $0.2016 after declining 9% on Tuesday.
    • Innovative International Acquisition Corp. (NASDAQ:IOAC) shares rose 36% to $11.66.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) shares gained 26% to $1.1708 after surging 29% on Tuesday.
    • Nephros, Inc. (NASDAQ:NEPH) rose 23% to $3.16.
    • SciSparc Ltd. (NASDAQ:SPRC) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 21% to $1.35. Eos Energy and Pine Gate Renewables announced partnership expansion with a minimum additional volume Of 500MWH.
    • Photronics, Inc. (NASDAQ:PLAB) gained 18.7% to $25.66 following fourth-quarter results.
    • Mynaric AG (NASDAQ:MYNA) shares surged 18.2% to $5.66 after the company received a $33 million order from Northrop Grumman.
    • QuantaSing Group Limited (NASDAQ:QSG) rose 17.2% to $2.4380 following first-quarter results.
    • Professional Diversity Network, Inc. (NASDAQ:IPDN) gained 16% to $2.8899.
    • Aurora Mobile Limited (NASDAQ:JG) shares gained 14% to $2.8254. Aurora Mobile said its subsidiary Wuhan SendCloud Technology Co., Ltd. has entered into a strategic partnership with Beijing Muhua Information Technology Co., Ltd.
    • ABM Industries Incorporated (NYSE:ABM) surged 13.6% to $50.38 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
    • LQR House Inc. (NASDAQ:LQR) rose 9.5% to $1.4126. LQR House announced its new marketing campaign for Soda Jerk.
    • Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) gained 7.4% to $384.03 after the company announced results from its Phase 2 study of VX-548 for the treatment of painful diabetic peripheral neuropathy.
    • REV Group, Inc. (NYSE:REVG) gained 7.3% to $18.31 following upbeat quarterly results.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) rose 6.3% to $51.96. Cal-Maine has temporarily ceased production at a facility in Kansas following an outbreak of avian influenza at the site.
    • Take-Two Interactive Software, Inc. (NASDAQ:TTWO) shares rose 3.5% to $162.64. Take-Two will be added to the Nasdaq-100 Index, effective prior to market open on Monday, Dec. 18, 2023.

    Losers

    • Hywin Holdings Ltd. (NASDAQ:HYW) shares fell 46.6% to $3.0001.
    • Boqii Holding Limited (NYSE:BQ) declined 33.3% to $0.6670.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 32.2% to $0.5497 as the company announced outcomes from meeting with the FDA regarding the company's next Phase 2 study supporting the advancement of next generation capecitabine for cancer patients.
    • Loop Media, Inc. (NASDAQ:LPTV) fell 28.3% to $0.9246 following fourth-quarter results.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) declined 27% to $0.1415. TC BioPharm announced plan to implement ADS ratio change.
    • SRIVARU Holding Limited (NASDAQ:SVMH) fell 25.5% to $0.3051.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) fell 24.6% to $0.2637.
    • Green Giant Inc. (NASDAQ:GGE) fell 18.8% to $0.0690. Green Giant recently announced pricing of its public offering.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) fell 16.2% to $0.46 after gaining 7% on Tuesday.
    • Blackboxstocks Inc. (NASDAQ:BLBX) fell 15.8% to $3.24. Blackboxstocks announced it executed a definitive agreement to acquire Evtec Aluminium Limited.
    • IN8bio, Inc. (NASDAQ:INAB) shares fell 10.8% to $1.46 after jumping 28% on Tuesday. IN8bio recently announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.
    • Target Hospitality Corp. (NYSE:TH) declined 11% to $9.74 as the company lowered its FY23 guidance.
    • Medifast, Inc. (NYSE:MED) fell 9% to $68.66. LifeMD announced a strategic alliance with Medifast to offer transformative weight management solution.
    • Pfizer Inc. (NYSE:PFE) declined 8.8% to $26.07 after the company provided FY24 guidance.
    • JetBlue Airways Corporation (NASDAQ:JBLU) fell 6.2% to $5.20.
    • Southwest Airlines Co. (NYSE:LUV) fell 6% to $28.51. Southwest Airlines sees fourth-quarter unit revenues to be down 9%-10% vs. prior view of down 9%-11%.

     

    Now Read This: Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

    Get the next $ABM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABM
    $BLBX
    $BQ
    $CALM

    CompanyDatePrice TargetRatingAnalyst
    Vertex Pharmaceuticals Incorporated
    $VRTX
    3/10/2026$580.00Buy
    Jefferies
    Vertex Pharmaceuticals Incorporated
    $VRTX
    3/10/2026$540.00 → $600.00Outperform
    Oppenheimer
    Shattuck Labs Inc.
    $STTK
    3/6/2026$25.00Buy
    Needham
    JetBlue Airways Corporation
    $JBLU
    3/2/2026$7.00Underweight → Equal Weight
    Barclays
    Pfizer Inc.
    $PFE
    3/2/2026$35.00Hold → Buy
    Argus
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Southwest Airlines Company
    $LUV
    2/27/2026$66.00Hold → Buy
    TD Cowen
    Pfizer Inc.
    $PFE
    2/25/2026$25.00Underperform
    RBC Capital Mkts
    More analyst ratings

    $ABM
    $BLBX
    $BQ
    $CALM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    JetBlue to Present at J.P. Morgan Industrials Conference

    JetBlue Airways Corporation (NASDAQ:JBLU) will present at the J.P. Morgan Industrials Conference at 8:50 a.m. ET on Tuesday, March 17th, 2026. A live, listen-only webcast of the call will be available on JetBlue's investor relations website at the following web address: http://investor.jetblue.com For those unable to listen to the live webcast, it will also be archived on JetBlue's investor relations website under 'Archived Events & Presentations' following the conference call. About JetBlue JetBlue is New York's Hometown Airline®, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando and San Juan. JetBlue carries customers to more than 100 cities throug

    3/10/26 4:30:00 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    Southwest Airlines to Present at the J.P. Morgan Industrials Conference

    DALLAS, March 10, 2026 /PRNewswire/ -- Southwest Airlines Co. (NYSE:LUV) has been invited to speak at the J.P. Morgan Industrials Conference. J.P. Morgan will be webcasting the audio presentation live, and a link to the webcast will be made available via the Investor Relations homepage on the Southwest Airlines website. Details of the audio webcast are as follows: Date:March 17, 2026Time: 11:30am EDTSpeakers: Bob Jordan, President, Chief Executive Officer, & Vice Chairman of the Board of DirectorsAndrew Watterson, Chief Operating OfficerTom Doxey, Executive Vice President and Chief Financial Officer Web Address: www.southwestairlinesinvestorrelations.comTo access the live audio webcast and s

    3/10/26 2:36:00 PM ET
    $LUV
    Air Freight/Delivery Services
    Consumer Discretionary

    SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

    TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a definitive share purchase agreement (the "SPA"), between NeuroThera, CliniQuantum Ltd. ("CliniQ") and the Selling Shareholders (as defined below) to acquire approximately 54.01% of the issued and outstanding ordinary shares of CliniQ (the "CliniQ Shares") on a fully diluted basis immediately prior to the closing

    3/10/26 9:28:00 AM ET
    $SPRC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABM
    $BLBX
    $BQ
    $CALM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 30, 2025 - FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

    For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.  Journavx is the first dr

    1/30/25 5:46:14 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABM
    $BLBX
    $BQ
    $CALM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Vertex Pharma with a new price target

    Jefferies initiated coverage of Vertex Pharma with a rating of Buy and set a new price target of $580.00

    3/10/26 8:43:03 AM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oppenheimer reiterated coverage on Vertex Pharma with a new price target

    Oppenheimer reiterated coverage of Vertex Pharma with a rating of Outperform and set a new price target of $600.00 from $540.00 previously

    3/10/26 8:19:07 AM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Needham resumed coverage on Shattuck Labs with a new price target

    Needham resumed coverage of Shattuck Labs with a rating of Buy and set a new price target of $25.00

    3/6/26 8:36:02 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABM
    $BLBX
    $BQ
    $CALM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gordon William B sold $521,725 worth of shares (2,500 units at $208.69), decreasing direct ownership by 4% to 57,014 units (SEC Form 4)

    4 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Issuer)

    3/10/26 4:08:17 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Director Dornemann Michael sold $296,195 worth of shares (1,390 units at $213.09), decreasing direct ownership by 6% to 21,525 units (SEC Form 4)

    4 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Issuer)

    3/6/26 4:51:45 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ABM
    $BLBX
    $BQ
    $CALM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Chief Executive Officer Mastrangelo Joe bought $157,262 worth of shares (23,900 units at $6.58), increasing direct ownership by 2% to 1,487,126 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/5/26 8:48:21 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Director Dimitrief Alexander bought $90,600 worth of shares (15,000 units at $6.04), increasing direct ownership by 7% to 235,221 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/4/26 8:56:17 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $ABM
    $BLBX
    $BQ
    $CALM
    SEC Filings

    View All

    SEC Form 10-Q filed by ABM Industries Incorporated

    10-Q - ABM INDUSTRIES INC /DE/ (0000771497) (Filer)

    3/10/26 2:17:01 PM ET
    $ABM
    Diversified Commercial Services
    Consumer Discretionary

    ABM Industries Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - ABM INDUSTRIES INC /DE/ (0000771497) (Filer)

    3/10/26 7:11:10 AM ET
    $ABM
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    3/6/26 7:43:59 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $ABM
    $BLBX
    $BQ
    $CALM
    Leadership Updates

    Live Leadership Updates

    View All

    The Show Never Stops in WWE® 2K26 King of Kings Edition, Attitude Era Edition, and Monday Night War Edition Available Now Worldwide

    Franchise evolution marked by improvements and additions to every game mode, four new match types, biggest roster ever, interactive environments, updated storylines, expanded customization features, and more Today, 2K announced King of Kings Edition, Attitude Era Edition, and Monday Night War Edition of WWE® 2K26, the newest installment of the flagship WWE video game franchise developed by Visual Concepts, are available now for PlayStation®5 (PS5®), Xbox Series X|S, Nintendo Switch™ 2, and PC via Steam. The Standard Edition, featuring cover star and current WWE World Heavyweight Champion, CM Punk, will be available on Friday, March 13, 2026. This press release features multimedia. View t

    3/6/26 8:00:00 AM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ABM
    $BLBX
    $BQ
    $CALM
    Financials

    Live finance-specific insights

    View All

    JetBlue to Present at J.P. Morgan Industrials Conference

    JetBlue Airways Corporation (NASDAQ:JBLU) will present at the J.P. Morgan Industrials Conference at 8:50 a.m. ET on Tuesday, March 17th, 2026. A live, listen-only webcast of the call will be available on JetBlue's investor relations website at the following web address: http://investor.jetblue.com For those unable to listen to the live webcast, it will also be archived on JetBlue's investor relations website under 'Archived Events & Presentations' following the conference call. About JetBlue JetBlue is New York's Hometown Airline®, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando and San Juan. JetBlue carries customers to more than 100 cities throug

    3/10/26 4:30:00 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    ABM Reports Fiscal First Quarter 2026 Results and Reaffirms Fiscal 2026 Outlook

    Revenue was $2.2 billion, an increase of 6.1% over the prior year, including organic growth of 5.5% Net income totaled $38.8 million, or $0.64 per diluted share, as compared to $43.6 million or $0.69 in the prior year Adjusted net income was $50.4 million, or $0.83 per diluted share, versus $55.3 million, or $0.87, in the prior yearAdjusted EBITDA was $117.8 million, versus $120.6 million last yearOperating cash flow was $62.0 million and free cash flow totaled $48.9 million, both up significantly over the prior yearThe Company repurchased $91.1 million of common stock during the quarter at an average price of $44.13 per share NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- ABM (NYSE:ABM), a

    3/10/26 6:58:00 AM ET
    $ABM
    Diversified Commercial Services
    Consumer Discretionary

    Cal-Maine Foods Schedules Third Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast

    RIDGELAND, Miss., March 09, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based prepared food industry, today announced it will report results for its fiscal 2026 third quarter at approximately 6:00 a.m. ET on Wednesday, April 1, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases. Management will review the results during a conference call and webcast at 9:00 a.m. ET the same day. Participants can access the live webcast on the Investor Relations page of the Cal-Maine Foods website at https://www.calmainefoods.com/events-pres

    3/9/26 4:30:00 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $ABM
    $BLBX
    $BQ
    $CALM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Shattuck Labs Inc.

    SC 13D/A - Shattuck Labs, Inc. (0001680367) (Subject)

    12/6/24 9:03:38 PM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care